Pathophysiology and therapeutic management of anemia in gastrointestinal disorders.


Journal

Expert review of gastroenterology & hepatology
ISSN: 1747-4132
Titre abrégé: Expert Rev Gastroenterol Hepatol
Pays: England
ID NLM: 101278199

Informations de publication

Date de publication:
Jul 2022
Historique:
pubmed: 14 6 2022
medline: 22 7 2022
entrez: 13 6 2022
Statut: ppublish

Résumé

Anemia is a common complication of gastrointestinal (GI) disorders, with a prevalence up to 60% in celiac disease (CeD) and inflammatory bowel disease (IBD). Iron deficiency anemia (IDA) is the most prevalent form of anemia in these conditions, but chronic inflammation and vitamin B12 deficiency represent other common contributing mechanisms, especially in IBD. We discuss the pathogenesis of anemia in various medical GI disorders, the sometime problematic distinction between IDA, anemia of inflammation (AI) and the association of the two, and therapeutic and preventive measures that can be useful for the management of anemia in GI disorders. Unfortunately, with the exception of IDA and AI in IBD, large RCT concerning the treatment of anemia in GI disorders are lacking. Anemia management strategies in GI disorders are outlined, with a focus on the main prevention, diagnostic, and therapeutic measures. Specific problems and situations such as the role of gluten-free diet for IDA treatment in CeD, the choice between oral and parenteral supplementation of iron or vitamin B12 in carential anemias, the use of endoscopic procedures to stop bleeding in intestinal angiodysplasia and preventive/treatment strategies for NSAID-associated GI bleeding are discussed.

Identifiants

pubmed: 35696485
doi: 10.1080/17474124.2022.2089114
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

625-637

Auteurs

Gaetano Bergamaschi (G)

Department of Internal Medicine, San Matteo Hospital Foundation, Pavia, Italy.

Flavio Caprioli (F)

Gastroenterology and Endoscopy Unit, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico and Università degli Studi di Milano, Milan, Italy.

Marco Vincenzo Lenti (MV)

Department of Internal Medicine, San Matteo Hospital Foundation, Pavia, Italy.
Department of Internal Medicine, University of Pavia, Pavia, Italy.

Luca Elli (L)

Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico of Milan, Milan, Italy.

Franco Radaelli (F)

Gastroenterology Unit, Valduce Hospital, Como, Italy.

Emanuele Rondonotti (E)

Gastroenterology Unit, Valduce Hospital, Como, Italy.

Caterina Mengoli (C)

Department of Internal Medicine, San Matteo Hospital Foundation, Pavia, Italy.

Emanuela Miceli (E)

Department of Internal Medicine, San Matteo Hospital Foundation, Pavia, Italy.

Chiara Ricci (C)

Gastroenterology Unit, Spedali Civili di Brescia and Department of Clinical and Experimental Sciences, University of Brescia, Brescia Italy.

Sandro Ardizzone (S)

Sacco, University of MilanGastroenterology and Digestive Endoscopy Unit, Department of Biochemical and Clinical Sciences L , Milano, Italy.

Maurizio Vecchi (M)

Gastroenterology and Endoscopy Unit, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico and Università degli Studi di Milano, Milan, Italy.

Antonio Di Sabatino (A)

Department of Internal Medicine, San Matteo Hospital Foundation, Pavia, Italy.
Department of Internal Medicine, University of Pavia, Pavia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH